Amarin Corp plc (AMRN) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Amarin Corp plc (AMRN) Misses Q3 EPS by 2c

Amarin Reports Third Quarter 2015 Financial Results and Provides Update on Operations

November 4, 2015 7:01 AM EST

BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 11/04/15 -- Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the three and nine months ended September 30, 2015, and provided an update on company operations.

Key Amarin achievements since June 30, 2015 include:

R&D progress: REDUCE-IT, the first prospective cardiovascular outcomes study to evaluate the effect of treating patients who despite statin therapy have elevated triglyceride levels... More